The Board denied the Veteran's claim for an annual VA clothing allowance for the 2020 calendar year due to the lack of a service-connected skin condition and evidence that the topical medications used caused irreparable damage to his clothes.
The deciding factor: The decision was based on the absence of a service-connected skin disability and the determination by VA that metronidazole and menthol salicylate do not cause clothing damage.
- Claimed conditions
- rosacea, back, hip, and leg pain
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- May 8, 2025
- Citation
- A25042058
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Dismissed
The appeal for service connection for back and bilateral knee conditions was withdrawn by the Veteran.
- Dismissed
The Veteran's appeal for increased ratings and service connection was dismissed due to a late filing.
- Dismissed
The Veteran withdrew the appeal for service connection for rosacea, GERD, chronic pain syndrome, and an acquired psychiatric disorder.
- Partly granted
The Board granted service connection for right thigh muscle spasm, left thigh muscle spasm, left calf muscle spasm, and right calf muscle spasm as secondary to the Veteran's service-connected hypertensive heart disease and hypertension. The claims for rectal bleeding and rosacea were remanded for further development.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.